BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.63B |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$260M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$258M |
| 5 |
Utilities Select Sector SPDR Fund
XLU
|
+$246M |
Top Sells
| 1 |
AGN.PRA
Allergan plc.
AGN.PRA
|
+$239M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$188M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$172M |
| 4 |
Amazon
AMZN
|
+$122M |
| 5 |
Johnson & Johnson
JNJ
|
+$95.8M |
Sector Composition
| 1 | Technology | 10.7% |
| 2 | Financials | 9.69% |
| 3 | Communication Services | 8.5% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Healthcare | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Flotek Industries
FTK
$341M
| $112K | ﹤0.01% |
3,053
-1,478
| -33% | -$54.1K |
|
|
BWP
2502
DELISTED
Boardwalk Pipeline Partners
BWP
| $110K | ﹤0.01% |
10,851
+10,850
| +1,085,000% | +$110K |
|
2503
Alaunos Therapeutics
TCRT
$5.1M
| $110K | ﹤0.01% |
187
+5
| +3% | +$2.94K |
|
2504
Scorpio Tankers
STNG
$2.99B
| $110K | ﹤0.01% |
5,599
-1,412
| -20% | -$27.7K |
|
2505
PennyMac Financial
PFSI
$6.44B
| $110K | ﹤0.01% |
4,844
-564
| -10% | -$12.8K |
|
2506
Franco-Nevada
FNV
$38.6B
| $109K | ﹤0.01% |
1,600
+900
| +129% | +$61.6K |
|
|
LJPC
2507
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $109K | ﹤0.01% |
3,674
+55
| +2% | +$1.64K |
|
2508
Cato Corp
CATO
$91.1M
| $109K | ﹤0.01% |
7,414
-3,069
| -29% | -$45.2K |
|
2509
Hamilton Lane
HLNE
$6.53B
| $109K | ﹤0.01% |
2,929
+92
| +3% | +$3.43K |
|
|
PERY
2510
DELISTED
Perry Ellis International Inc
PERY
| $108K | ﹤0.01% |
4,202
-3,261
| -44% | -$84.1K |
|
2511
Omeros
OMER
$282M
| $108K | ﹤0.01% |
9,704
+164
| +2% | +$1.83K |
|
2512
Rigel Pharmaceuticals
RIGL
$681M
| $108K | ﹤0.01% |
3,055
+51
| +2% | +$1.81K |
|
2513
TruBridge
TBRG
$302M
| $108K | ﹤0.01% |
3,703
-1,303
| -26% | -$38K |
|
2514
Tucows
TCX
$204M
| $108K | ﹤0.01% |
1,930
+36
| +2% | +$2.02K |
|
2515
Hawkins
HWKN
$3.62B
| $108K | ﹤0.01% |
6,124
-2,594
| -30% | -$45.6K |
|
2516
Beazer Homes USA
BZH
$781M
| $107K | ﹤0.01% |
6,734
-64,875
| -91% | -$1.03M |
|
2517
Daktronics
DAKT
$1.15B
| $107K | ﹤0.01% |
12,141
-3,706
| -23% | -$32.7K |
|
2518
Aqua Metals
AQMS
$5.15M
| $107K | ﹤0.01% |
206
+189
| +1,112% | +$98K |
|
|
ROCC
2519
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $106K | ﹤0.01% |
3,026
-23,440
| -89% | -$821K |
|
2520
Karyopharm Therapeutics
KPTI
$55.9M
| $106K | ﹤0.01% |
526
+51
| +11% | +$10.3K |
|
|
BHBK
2521
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $106K | ﹤0.01% |
5,064
-5
| -0.1% | -$104 |
|
2522
PDF Solutions
PDFS
$765M
| $105K | ﹤0.01% |
9,030
-2,554
| -22% | -$29.8K |
|
2523
Greenlight Captial
GLRE
$426M
| $105K | ﹤0.01% |
6,546
-2,176
| -25% | -$34.9K |
|
|
GTHX
2524
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $105K | ﹤0.01% |
2,835
+1,045
| +58% | +$38.7K |
|
2525
Cytokinetics
CYTK
$6.12B
| $105K | ﹤0.01% |
14,586
-4,727
| -24% | -$34K |
|